PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 7383 (118th)

RARE Act

referredUnited States· United States Congress· EN

Introduced

15 February 2024

Last action

16 February 2024 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Matsui, Doris O. [D-CA-7], Rep. Bilirakis, Gus M. [R-FL-12], Richard Hudson

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Summary

Retaining Access and Restoring Exclusivity Act or the RARE Act This bill specifies that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drug exclusivity period) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. Current law grants a seven-year period of market exclusivity for an approved orphan drug, during which the Food and Drug Administration (FDA) may not approve an application from another manufacturer for the same drug for the same disease or condition. The FDA's regulations provide that this exclusivity is specific to the same approved use or indication of the drug, rather than all uses or indications, for the disease or condition. However, in Catalyst Pharmaceuticals, Inc. v. Becerra, a court held that exclusivity did extend to all uses or indications for the disease or condition. The bill provides statutory authority for the FDA's regulations.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 15 February 2024

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 15 February 2024

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 15 February 2024

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 16 February 2024

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.